Do female patients with metabolic syndrome have masked left ventricular dysfunction? [4]

Anadolu Kardiyoloji Dergisi

Volumn 6, Issue 1, 2006, Pages 89-91

  Yilmaz, Remzi ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; IMAGE QUALITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; METABOLIC SYNDROME X; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; RELIABILITY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

FEMALE; HUMANS; METABOLIC SYNDROME X; MYOCARDIAL CONTRACTION; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33645049322     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (34)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) 2001 JAMA 285:2486-97.
2. Hanley AJ, Karter AJ, Festa A, D'Agostino R Jr, Wagenknecht LE, Savage P, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51:2642-7.
3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-9.
4. Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2):135-48.
5. Di Bello V, Giampietro O, Pedrinelli R, Matteucci E, Giorgi D, Bertini A, et al. Can insulin action induce myocardial texture alterations in essential hypertension? Am J Hypertens 1999; 12:283-90.
6. Hara-Nakamura N, Kohara K, Sumimoto T, Lin M, Hiwada K. Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens 1994; 7:1110-4.
7. Ferrannini E, Stern MP. Primary insulin resistance: a risk syndrome. In: Leslie RDG, Robbins DC, editors. Diabetes: Clinical Science in Practice. Cambridge, UK: Cambridge University Press; 1995. p.200-20.
8. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, et al. Associations of insulin levels with left ventricular structure and function in American Indians: the Strong Heart Study. Diabetes 2002; 51:1543-7.
9. Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993; 88:1431-6.
10. Sharp SD, Williams RR. Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology 1992; 81:207-12.
11. Yilmaz R, Seydaliyeva T, Unlu D, Ulucay A. The effect of left ventricular geometry on myocardial performance index in hypertensive patients Anadolu Kardiyol Derg 2004; 4:217-22.
12. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004; 93:40-4.
13. Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M, et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001; 87:1260-5.
14. Paolisso G, Galderisi M, Tagliamonte MR, de Divitis M, Galzerano D, Petrocelli A, et al. Myocardial wall thickness and left ventricular geometry in hypertensives. Relationship with insulin. Am J Hypertens 1997; 10:1250-6.
15. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004; 43:1399-404.
16. de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A, et al. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 2002; 20:323-31.
17. Sundstrom J, Lind L, Vessby B, Andren B, Aro A, Lithell H. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001; 103:836-41.
18. Ferrara AL, Vaccaro O, Cardoni O, Panarelli W, Laurenzi M, Zanchetti A. Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio Study. Nutr Metab Cardiovasc Dis 2003; 13:126-32.
19. Rademakers FE, Rogers WJ, Guier WH, Hutchins GM, Siu CO, Weisfeldt ML, et al. Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging. Circulation 1994; 89:1174-82.
20. Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90:928-36.
21. Vetta F, Cicconetti P, Ronzoni S, Rizzo V, Palleschi L, Canarile G, et al. Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J 1998; 19:326-31.
22. Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S. Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab 1998; 83:4284-8.
23. Rheeder P, Stolk RP, Mosterd A, Pols HA, Hofman A, Grobbee DE. Insulin resistance syndrome and left ventricular mass in an elderly population (The Rotterdam Study). Am J Cardiol 1999; 84:233-6.
24. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13:433-8.
25. Celentano A, Crivaro M, Roman MJ, Pietropaolo I, Greco R, Pauciullo P, et al. Left ventricular geometry and arterial function in hypercholesterolemia. Nutr Metab Cardiovasc Dis 2001; 11:312-9.
26. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study, Circulation 2003; 107:448-54.
27. Dursunoglu D, Evrengul H, Tanriverdi H, Kuru O, Gur S, Kaftan A, et al. Do female patients with metabolic syndrome have masked left ventricular dysfunction? Anadolu Kardiyol Derg 2005; 5:283-8.
28. Shapiro LM. Echocardiographic features of impaired ventricular function in diabetes mellitus. Br Heart J 1982; 47:439-44.
29. Alam M, Hoglund C, Thorstrand C. Longitudinal systolic shortening of the left ventricle: an echocardiographic study in subjects with and without preserved global function. Clin Physiol 1992; 12:443-52.
30. Hoglund C, Alam M, Thorstrand C. Atrioventricular valve plane displacement in healthy persons. An echocardiographic study. Acta Med Scand 1988; 224:557-62.
31. Alam M, Hoglund C. Assessment by echocardiogram of left ventricular diastolic function in healthy subjects using the atrioventricular plane displacement. Am J Cardiol 1992; 69:565-8.
32. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26:357-66.
33. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10:169-78.
34. Dujardin KS, Tei C, Yeo TC, Hodge DO, Rossi A, Seward JB. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy, Am J Cardiol 1998; 82:1071-6.